4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Clinical trial NCT05197270 · RECRUITING
Trial details
- NCT number
- NCT05197270
- Sponsor
- 4D Molecular Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2027-03-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.